A systematic review on the genotoxic effect of serotonin and norepinephrine reuptake inhibitors (SNRIs) antidepressants

[1] Abdel-Wahab BA(2011)Venlafaxine protects against stress-induced oxidative DNA damage in hippocampus during antidepressant testing in mice Pharmacol Biochem Behav 100 59-65

[2] Salama RH(2019)Effects of selective serotonin reuptake inhibitors on DNA damage in patients with depression J Psychopharmacol 33 1364-1376

[3] Ahmadimanesh M(2017)Evaluation of cytogenetic and DNA damage induced by the antidepressant drug-active ingredients, trazodone and milnacipran, in vitro Drug Chem Toxicol 40 57-66

[4] Abbaszadegan MR(1992)Biochemical and toxicological properties of the oxidation products of catecholamines Free Radic Biol Med 13 391-405

[5] Morshedi Rad D(2007)Risk of cancer associated with the use of antidepressants Rev Psiquiatr Rio Gd Sul 29 63-69

[6] Moallem SA(2007)Genotoxic and carcinogenic risk to humans of drug–nitrite interaction products Mutat Res Rev Mutat Res 635 17-52

[7] Mohammadpour AH(2009)Genotoxic and carcinogenic effects of antipsychotics and antidepressants Toxicology 261 77-88

[8] Ghahremani MH(2017)Assessment of genotoxic effect induced by some antidepressant drugs employing a variety of short-term genotoxic bioassays Alex Sci Exch J 38 185-192

[9] Farid Hosseini F(2007)Duloxetine: review of its pharmacology, and therapeutic use in depression and other psychiatric disorders Ann Clin Psychiatry 19 125-132

[10] Behdani F(2001)Role of free radicals in the neurodegenerative diseases Drugs Aging 18 685-716

[1] Abdel-Wahab BA(2011)Venlafaxine protects against stress-induced oxidative DNA damage in hippocampus during antidepressant testing in mice Pharmacol Biochem Behav 100 59-65

[2] Salama RH(2019)Effects of selective serotonin reuptake inhibitors on DNA damage in patients with depression J Psychopharmacol 33 1364-1376

[3] Ahmadimanesh M(2017)Evaluation of cytogenetic and DNA damage induced by the antidepressant drug-active ingredients, trazodone and milnacipran, in vitro Drug Chem Toxicol 40 57-66

[4] Abbaszadegan MR(1992)Biochemical and toxicological properties of the oxidation products of catecholamines Free Radic Biol Med 13 391-405

[5] Morshedi Rad D(2007)Risk of cancer associated with the use of antidepressants Rev Psiquiatr Rio Gd Sul 29 63-69

[6] Moallem SA(2007)Genotoxic and carcinogenic risk to humans of drug–nitrite interaction products Mutat Res Rev Mutat Res 635 17-52

[7] Mohammadpour AH(2009)Genotoxic and carcinogenic effects of antipsychotics and antidepressants Toxicology 261 77-88

[8] Ghahremani MH(2017)Assessment of genotoxic effect induced by some antidepressant drugs employing a variety of short-term genotoxic bioassays Alex Sci Exch J 38 185-192

[9] Farid Hosseini F(2007)Duloxetine: review of its pharmacology, and therapeutic use in depression and other psychiatric disorders Ann Clin Psychiatry 19 125-132

[10] Behdani F(2001)Role of free radicals in the neurodegenerative diseases Drugs Aging 18 685-716